Ada (n=16) | Placebo (n=15) | All (n=31) | |
---|---|---|---|
Female, n (%) | 15 (94) | 13 (87) | 28 (90) |
Age, median value, years [ranges] | 10.8 [5.0–20.3] | 9.2 [4.9–29.1] | |
Active joints, median n [ranges] | 0 [0–3] | 0 [0–4] | 0 [0–4] |
Uveitis median duration, years [ranges] | 4.4 [0.4–18.9] | 4.8 [0.6–24.2] | |
Laser flare (ph/ms), median [ranges] | 99 [23–322] | 70 [36–265] | |
Bilateral uveitis, n (%) | 10 (63) | 14 (93) | 24 (78) |
Ongoing treatments at D1 | |||
Oral steroids, patients n (%) | 7 (44) | 3 (20) | 10 (32) |
Methotrexate, patients n (%) | 15 (94) | 11 (73) | 26 (84) |